(c) 2024 PillSync.com

tizanidine tablet

1 INDICATIONS AND USAGE Tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important. ( 1 ) Tizanidine is indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important [see Dosage and Administration ( 2.1 )] .

unichem pharmaceuticals (usa), inc.


6 years ago ROUND WHITE U 168 tizanidine tablet

ROUND WHITE U 168

6 years ago ROUND WHITE U 168 tizanidine tablet

U 168 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.2

TIZANIDINE Tablets

TIZANIDINE (

TIZANIDINE hydrochloride) tablets, USP are available as white to off-white, round, flat, bevel edged uncoated tablets containing 2 mg or 4 mg of

TIZANIDINE.

TIZANIDINE tablets USP, 2 mg are debossed with "U" and "168" on one side and bisecting score on other side. Bottles of 90: NDC 29300-168-19 Bottles of 150: NDC 29300-168-15 Bottles of 500: NDC 29300-168-05 Bottles of 1,000: NDC 29300-168-10

TIZANIDINE tablets USP, 4 mg are debossed with "U" and "169" on one side and quadrisecting score on other side. Bottles of 90: NDC 29300-169-19 Bottles of 150: NDC 29300-169-15 Bottles of 300: NDC 29300-169-03 Bottles of 500: NDC 29300-169-05 Bottles of 1,000: NDC 29300-169-10 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in tight, light-resistant container [see USP].


More pills like ROUND U 168

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site